SPI Healthcare
3.553,80
PKT
+36,60
PKT
+1,04
%
Werbung
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.08.23 | Roche Underweight | JP Morgan Chase & Co. | |
23.08.23 | Roche Equal Weight | Barclays Capital | |
23.08.23 | Roche Underweight | JP Morgan Chase & Co. | |
15.08.23 | Novartis Buy | Deutsche Bank AG | |
10.08.23 | Novartis Underweight | Barclays Capital | |
31.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
28.07.23 | Roche Equal Weight | Barclays Capital | |
28.07.23 | Roche Sell | Deutsche Bank AG | |
28.07.23 | Roche Outperform | Credit Suisse Group | |
27.07.23 | Roche Hold | Jefferies & Company Inc. | |
27.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
26.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
25.07.23 | Roche Sell | Deutsche Bank AG | |
24.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
19.07.23 | Novartis Buy | Deutsche Bank AG | |
19.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.07.23 | Novartis Neutral | UBS AG | |
18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.07.23 | Novartis Buy | Jefferies & Company Inc. | |
10.07.23 | Novartis Buy | Deutsche Bank AG | |
06.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
05.07.23 | Roche Hold | Jefferies & Company Inc. | |
05.07.23 | Novartis Buy | Jefferies & Company Inc. | |
29.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
22.06.23 | Roche Sell | Deutsche Bank AG | |
20.06.23 | Roche Sell | Deutsche Bank AG | |
15.06.23 | Novartis Underweight | Barclays Capital | |
15.06.23 | Roche Neutral | UBS AG | |
15.06.23 | Novartis Neutral | UBS AG | |
13.06.23 | Novartis Buy | Deutsche Bank AG | |
09.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
08.06.23 | Roche Hold | Jefferies & Company Inc. | |
06.06.23 | Novartis Buy | Deutsche Bank AG | |
05.06.23 | Novartis Neutral | UBS AG | |
05.06.23 | Roche Equal Weight | Barclays Capital | |
05.06.23 | Novartis Buy | Deutsche Bank AG | |
05.06.23 | Novartis Underweight | Barclays Capital | |
05.06.23 | Roche Underweight | JP Morgan Chase & Co. |